Re‐exploration after off‐pump coronary artery bypass grafting: Incidence, risk factors, and impact of timing

Objective Re‐exploration after cardiac surgery still remains a troublesome complication. There is still a scarcity of data about the effect of re‐exploration after off‐pump coronary artery bypass grafting (OPCABG). We here represent our experience on re‐exploration following OPCABG. Method A total o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cardiac surgery 2020-11, Vol.35 (11), p.3062-3069
Hauptverfasser: Patel, Kartik, Adalti, Sudhir, Runwal, Shreyas, Singh, Rahul, Ananthanarayanan, Chandrasekaran, Doshi, Chirag, Pandya, Himani
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective Re‐exploration after cardiac surgery still remains a troublesome complication. There is still a scarcity of data about the effect of re‐exploration after off‐pump coronary artery bypass grafting (OPCABG). We here represent our experience on re‐exploration following OPCABG. Method A total of 5990 OPCABG were performed at our center, out of these patients, 132 (2.2%) were re‐explored in the operation room and were included in this study. The medical records of these patients were retrospectively reviewed. Results The most common cause of re‐exploration was bleeding (83.3%) and the most common site of bleeding was from graft/anastomosis (53.8%). The mean time to re‐exploration was 9.75 ± 8.65 hours. The thirty‐day mortality was 1.41%. On univariate and multiple regression analysis, emergency surgery, preoperative low platelet count, and the number of grafts were found to be independent risk factors for re‐exploration. On multiple regression, emergency surgery, Euroscore II, low platelet count, low ejection fraction, re‐exploration, time to re‐exploration, blood products used, and high postoperative serum creatinine and bilirubin were found to be independent factors (P 14 hours) had significantly high mortality (30.55% vs 7.3%) and morbidity. Conclusion Delaying re‐exploration is associated with a three fold increase in mortality and morbidity. So, a strategy of minimizing the incidence of re‐exploration, like the use of minimally invasive surgery and early re‐exploration with the judicial use of products, should be used to improve outcomes after re‐exploration following OPCABG.
ISSN:0886-0440
1540-8191
DOI:10.1111/jocs.14986